Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johnson & Johnson Enterprise Innovation Inc.
New Brunswick, New Jersey, United Statesjnj.com ↗
- Ownership
- Private
- Employees
- ~138000
- Development stage
- Other
01
Overview
Johnson & Johnson maintains a broad clinical pipeline with ongoing advances in oncology, immunology, neuroscience, and infectious diseases; recent FDA approvals include new therapies for bladder cancer and psoriasis, and it is among the global leaders in therapeutic innovation.
- Therapeutic areas
- ImmunologyInfectious DiseasesDermatologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyGene therapyVaccineDeviceBiologic
- Industry
- Pharma
02
Partnerships
Collaborations with academic institutions, startups, and major pharma companies worldwide through the innovation centers
Beyond the preview
Go deeper on Johnson & Johnson Enterprise Innovation Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Johnson & Johnson Enterprise Innovation Inc..